Selected article for: "PCR amplification and real time PCR amplification"
Author: Dierks, Sascha; Bader, Oliver; Schwanbeck, Julian; Groß, Uwe; Weig, Michael S.; Mese, Kemal; Lugert, Raimond; Bohne, Wolfgang; Hahn, Andreas; Feltgen, Nicolas; Torkieh, Setare; Denker, Fenja R.; Lauermann, Peer; Storch, Marcus W.; Frickmann, Hagen; Zautner, Andreas Erich
Title: Diagnosing SARS-CoV-2 with Antigen Testing, Transcription-Mediated Amplification and Real-Time PCR
  • Cord-id: j6w49f18
  • Document date: 2021_5_29
    • ID: j6w49f18
    Snippet: This study was performed as a head-to-head comparison of the performance characteristics of (1) two SARS-CoV-2-specific rapid antigen assays with real-time PCR as gold standard as well as (2) a fully automated high-throughput transcription-mediated amplification (TMA) assay and real-time PCR in a latent class analysis-based test comparison without a gold standard with several hundred samples in a low prevalence “real world” setting. Recorded sensitivity and specificity of the NADAL and the L
    Document: This study was performed as a head-to-head comparison of the performance characteristics of (1) two SARS-CoV-2-specific rapid antigen assays with real-time PCR as gold standard as well as (2) a fully automated high-throughput transcription-mediated amplification (TMA) assay and real-time PCR in a latent class analysis-based test comparison without a gold standard with several hundred samples in a low prevalence “real world” setting. Recorded sensitivity and specificity of the NADAL and the LumiraDx antigen assays and the Hologic Aptima SARS-CoV-2 TMA assay were 0.1429 (0.0194, 0.5835), 0.7644 (0.7016, 0.8174), and 0.7157 (0, 1) as well as 0.4545 (0.2022, 0.7326), 0.9954 (0.9817, 0.9988), and 0.9997 (not estimable), respectively. Agreement kappa between the positive results of the two antigen-based assays was 0.060 (0.002, 0.167) and 0.659 (0.492, 0.825) for TMA and real-time PCR. Samples with low viral load as indicated by cycle threshold (Ct) values > 30 were generally missed by both antigen assays, while 1:10 pooling suggested higher sensitivity of TMA compared to real-time PCR. In conclusion, both sensitivity and specificity speak in favor of the use of the LumiraDx rather than the NADAL antigen assay, while TMA results are comparably as accurate as PCR, when applied in a low prevalence setting.

    Search related documents:
    Co phrase search for related documents
    • abbott usa il chicago and acute respiratory: 1
    • abbott usa il chicago and acute respiratory syndrome: 1
    • acceptable sensitivity and accuracy studies: 1, 2, 3
    • acceptable sensitivity and acute respiratory: 1, 2, 3, 4, 5, 6
    • acceptable sensitivity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • acceptable sensitivity and low number: 1, 2
    • accuracy studies and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accuracy studies and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accuracy studies and low number: 1
    • accuracy studies and low prevalence: 1, 2, 3
    • acute respiratory and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and low prevalence community: 1, 2, 3
    • acute respiratory and low prevalence population: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low prevalence community: 1, 2, 3
    • acute respiratory syndrome and low prevalence population: 1, 2, 3, 4, 5, 6, 7, 8